WeLeader Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	237.71	174.97	94.69	100.73	111.52
Short-Term Investments	97	34.37	7.83	8.4	4.18
Trading Asset Securities	-	2.83	2.43	2.33	3.01
Cash & Short-Term Investments	334.71	212.17	104.95	111.45	118.71
Cash Growth	57.76%	102.16%	-5.83%	-6.11%	-
Accounts Receivable	322.51	276.87	273.63	279.43	290.68
Other Receivables	-	-	0.05	0.1	1.03
Receivables	322.51	276.87	273.69	279.52	291.71
Inventory	117.93	99.06	69.67	62.73	55.89
Other Current Assets	5.23	3.21	2.11	1.02	2.11
Total Current Assets	780.39	591.32	450.42	454.73	468.42
Property, Plant & Equipment	1,589	1,341	1,194	1,086	351.66
Long-Term Investments	43.13	26.82	42.87	27.84	29.6
Other Intangible Assets	2.47	4.06	3.88	5.74	6.13
Long-Term Deferred Tax Assets	0.67	0.46	0.69	0.79	0.49
Other Long-Term Assets	33.5	34.63	36.02	25.24	26.8
Total Assets	2,449	1,998	1,728	1,600	883.09
Accounts Payable	214.45	183.54	143.19	155.28	160.65
Accrued Expenses	68.9	56.82	55.27	48.18	44.01
Short-Term Debt	-	80	57	121.03	53
Current Portion of Long-Term Debt	1.03	17.44	16.97	15.02	13.63
Current Portion of Leases	95.52	81.43	74.62	49.75	53.93
Current Income Taxes Payable	31.06	25.54	23.87	34.46	23.84
Current Unearned Revenue	5.2	1.52	0.34	0.7	1.95
Other Current Liabilities	16.15	22.71	30.43	14.13	12.81
Total Current Liabilities	432.3	469.01	401.69	438.54	363.81
Long-Term Debt	488.43	397.96	249.03	270.23	18.65
Long-Term Leases	268.14	219.94	228.38	245.22	142.99
Long-Term Deferred Tax Liabilities	-	-	-	-	0
Other Long-Term Liabilities	-	2.69	2.69	0.2	0.22
Total Liabilities	1,189	1,090	881.78	954.19	525.68
Common Stock	454.79	415.79	415.79	342.46	193.49
Additional Paid-In Capital	384.31	141.13	141.13	92.96	8.73
Retained Earnings	406.54	351.16	276.57	213.89	155.2
Comprehensive Income & Other	14.49	0.39	12.29	-3.01	-
Shareholders' Equity	1,260	908.47	845.78	646.3	357.41
Total Liabilities & Equity	2,449	1,998	1,728	1,600	883.09
Total Debt	853.11	796.77	626	701.25	282.19
Net Cash (Debt)	-518.4	-584.6	-521.05	-589.79	-163.49
Net Cash Per Share	-11.16	-14.01	-12.68	-19.38	-5.82
Filing Date Shares Outstanding	45.48	41.58	41.59	34.25	27.88
Total Common Shares Outstanding	45.48	41.58	41.59	34.25	27.88
Working Capital	348.08	122.31	48.73	16.19	104.61
Book Value Per Share	27.71	21.85	20.34	18.87	12.82
Tangible Book Value	1,258	904.41	841.9	640.56	351.28
Tangible Book Value Per Share	27.65	21.75	20.24	18.70	12.60
Land	652.61	652.61	652.61	657.23	4.62
Buildings	-	-	-	11.93	11.93
Machinery	20.01	19.46	28.53	25.97	24.65
Construction In Progress	519.58	318.14	144.95	7.43	0.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.